Giuseppe Pelosi Selected Research

Giuseppe Pelosi Research Topics

Disease

88	Neoplasms (Cancer) 02/2024 - 05/2002
33	Carcinoma (Carcinomatosis) 10/2021 - 05/2002
29	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2003
21	Carcinoid Tumor (Carcinoid) 05/2024 - 11/2003
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 11/2003
14	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2021 - 03/2005
12	Adenocarcinoma 01/2024 - 01/2006
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 01/2006
10	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2003
10	Small Cell Carcinoma 01/2020 - 11/2003
5	Adenosquamous Carcinoma 10/2021 - 06/2011
5	Colorectal Neoplasms (Colorectal Cancer) 10/2018 - 03/2008
5	Neoplasm Metastasis (Metastasis) 11/2017 - 09/2005
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2011 - 05/2002
4	Adenocarcinoma of Lung 12/2021 - 12/2013
4	Mesothelioma 01/2017 - 06/2010
4	Large Cell Carcinoma 06/2013 - 04/2008
3	Inflammation (Inflammations) 01/2024 - 03/2010
3	Neuroendocrine Carcinoma 03/2021 - 12/2005
3	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 05/2007
3	Hyperplasia 11/2019 - 08/2011
3	Disease Progression 04/2016 - 05/2007
3	Carcinosarcoma 06/2013 - 04/2012
3	Sarcoma (Soft Tissue Sarcoma) 04/2011 - 05/2004
3	Lymphatic Metastasis 03/2006 - 11/2003
2	Idiopathic Pulmonary Fibrosis 06/2022 - 03/2010
2	Retinoblastoma (Glioblastoma, Retinal) 01/2019 - 07/2017
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 04/2017 - 08/2014
2	Melanoma (Melanoma, Malignant) 01/2015 - 02/2012
2	Pulmonary Blastoma 09/2012 - 04/2012
2	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 06/2011 - 07/2006

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2003
11	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2003
9	Ki-67 Antigen (Ki 67 Antigen)IBA 05/2024 - 09/2003
7	Messenger RNA (mRNA)IBA 11/2021 - 01/2006
7	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 11/2003
7	VimentinIBA 07/2017 - 09/2003
6	SynaptophysinIBA 10/2021 - 05/2003
6	ErbB Receptors (EGF Receptor)IBA 12/2013 - 12/2004
6	Tamoxifen FDA LinkGeneric 11/2009 - 06/2003
6	fascinIBA 04/2007 - 05/2003
5	Chromogranin AIBA 04/2017 - 05/2003
5	Protein Isoforms (Isoforms)IBA 11/2013 - 07/2006
4	Thyroid Nuclear Factor 1IBA 01/2019 - 06/2011
4	MucinsIBA 01/2018 - 05/2009
4	Eosine Yellowish-(YS) (Eosin)IBA 10/2017 - 02/2005
4	Hematoxylin (Haematoxylon)IBA 10/2017 - 02/2005
4	AsbestosIBA 01/2016 - 01/2006
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016 - 05/2007
4	Gefitinib (Iressa)FDA Link 12/2013 - 02/2005
3	Anaplastic Lymphoma KinaseIBA 04/2024 - 09/2012
3	CateninsIBA 10/2021 - 04/2016
3	Coloring Agents (Dyes)IBA 10/2017 - 05/2009
3	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2017 - 07/2006
3	Keratin-7 (Cytokeratin 7)IBA 04/2017 - 06/2009
3	ChromatinIBA 01/2017 - 02/2005
3	Cadherins (E-Cadherin)IBA 04/2016 - 11/2003
3	MicroRNAs (MicroRNA)IBA 10/2015 - 08/2011
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2015 - 11/2006
3	ParaffinIBA 06/2014 - 04/2008
3	Insulin-Like Growth Factor I (IGF-1)IBA 08/2009 - 06/2003
3	Hormones (Hormone)IBA 05/2007 - 05/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2016
2	Histones (Histone)IBA 03/2021 - 01/2017
2	B7-H1 AntigenIBA 01/2021 - 01/2020
2	xylometazoline (stas)IBA 01/2020 - 11/2019
2	Circulating MicroRNAIBA 10/2019 - 10/2015
2	ChromograninsIBA 01/2019 - 04/2011
2	Gemcitabine FDA Link 03/2018 - 04/2011
2	Oncogene Proteins (Oncogene Protein)IBA 11/2017 - 01/2016
2	Nuclear Proteins (Protein, Nuclear)IBA 11/2017 - 04/2017
2	Cyclin D1IBA 07/2017 - 12/2005
2	Colloids (Colloid)IBA 04/2017 - 08/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 04/2017 - 05/2002
2	PlasticsIBA 12/2016 - 06/2007
2	Alkaline PhosphataseIBA 04/2016 - 07/2006
2	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 05/2010
2	Phosphotransferases (Kinase)IBA 04/2015 - 05/2008
2	Monoclonal AntibodiesIBA 01/2015 - 11/2003
2	LigandsIBA 01/2015 - 08/2008
2	AntibodiesIBA 08/2014 - 12/2010
2	Tyrosine Kinase InhibitorsIBA 04/2014 - 11/2006
2	Cetuximab (Erbitux)FDA Link 01/2014 - 03/2008
2	Imatinib Mesylate (Gleevec)FDA Link 08/2013 - 08/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2012 - 06/2004
2	DesmocollinsIBA 11/2011 - 05/2009
2	DesminIBA 04/2011 - 09/2003

Therapy/Procedure

29	Therapeutics 04/2024 - 05/2002
15	Drug Therapy (Chemotherapy) 01/2022 - 05/2002
5	Immunotherapy 12/2021 - 01/2015
4	Neoadjuvant Therapy 01/2020 - 11/2004
3	Radiotherapy 11/2017 - 05/2002
3	Induction Chemotherapy 11/2017 - 12/2004
3	Adjuvant Chemotherapy 04/2016 - 11/2006
3	Lymph Node Excision (Lymph Node Dissection) 04/2011 - 03/2006
3	Pneumonectomy (Lung Volume Reduction) 03/2010 - 01/2005
2	Chemoprevention 11/2019 - 11/2003
2	Lasers (Laser) 03/2018 - 05/2014
2	Precision Medicine 01/2018 - 06/2014